Search Videos and More
UT Southwestern’s Siegwart Lab is Building Tomorrow’s Cancer Cures From the Inside Out
The Siegwart Lab Program in Genetic Drug Engineering uses nanoparticle technology to create anti-cancer medicines generated within the human body.Simmons Cancer Center earns exceptional rating in its renewal as an NCI-designated Comprehensive Cancer Center
National Cancer Institute reaffirms UT Southwestern’s place among the country’s elite comprehensive cancer centersState’s investment in cancer research has helped draw top talent to UTSW
15 years of CPRIT recruitment grants have spurred UTSW’s efforts to build leading cancer research programs and advance innovative patient care at Simmons Cancer CenterUTSW study identifies factors affecting survival of patients with metastatic breast cancer
Researchers discover two new groups of antigen-presenting fibroblasts that play important roles in cancer’s growth, spread, and resistance to chemotherapyUTSW named Specialized Program of Research Excellence for liver cancer
$12 million award from National Cancer Institute will advance promising research toward improving patient carePersonalized Medicine: Enabling Real-time Radiation Treatment Modifications, ART Targets Cancer More Precisely
Shahed Badiyan, M.D., Associate Professor of Radiation Oncology, and Mu-Han Lin, Ph.D., Professor of Radiation Oncology, co-lead the Adaptive Radiation Therapy (ART) Program at UT Southwestern Medical Center, one of the largest of its kind in the world. ART is an innovative radiation treatment technology that enables radiation oncologists to modify the radiation plan in real time, offering fully personalized treatments for each patient.UT Southwestern is best hospital in DFW for ninth straight year
Twelve specialties are nationally ranked – the most of any hospital in Texas – by U.S. News & World ReportPresurgical radiation may curb pancreatic cancer recurrence
Combining ablative radiotherapy with chemotherapy prior to pancreatic cancer surgery reduces risk of regrowth, stimulates immune system, UTSW researchers findTime in a bottle: How UTSW paved the way for a breakthrough brain cancer drug
Nearly two decades of innovative research and clinical trials culminated in the FDA approval of a pill that gives fresh hope to low-grade glioma patientsGene-editing system targets multiple organs simultaneously
Tool developed at UT Southwestern corrects mutation that affects the liver and lungs in model of rare genetic diseaseProtein pivotal for B-cell cancers gets a closer look
Structural insights from cryo-electron microscopy could lead to drugs that target midnolin in leukemias, lymphomas, and multiple myelomasStudy uncovers how biomolecular condensates cause some kidney cancers
Mechanism discovered by UTSW researchers could offer targets for novel cancer therapies